Original language | English |
---|---|
Pages (from-to) | 1939-1944 |
Journal | Annals of the Rheumatic Diseases |
Volume | 75 |
Issue number | 11 |
DOIs | |
Publication status | Published - Nov 2016 |
Disease activity-guided dose optimisation of adalimumab and etanercept is a cost-effective strategy compared with non-tapering tight control rheumatoid arthritis care: analyses of the DRESS study
Wietske Kievit*, Noortje van Herwaarden, Frank H. J. van den Hoogen, Ronald F. van Vollenhoven, Johannes W. J. Bijlsma, Bart J. F. van den Bemt, Aatke van der Maas, Alfons A. den Broeder
*Corresponding author for this work
Research output: Contribution to journal › Article › Academic › peer-review
29
Citations
(Web of Science)